Does losing weight reduce recurrence risk?

Many studies have found that women who are living with obesity when diagnosed with breast cancer, or who gain a lot of weight afterwards, tend to have a higher risk of the cancer coming back and of dying from breast cancer than women at a healthier weight. This link is seen particularly in hormone receptor positive cancer and in postmenopausal women. Several reasons are thought to explain it. After menopause, fat tissue is the main source of oestrogen, so more body fat can mean higher oestrogen levels. Excess weight is also associated with higher insulin levels, chronic low-grade inflammation and other growth-promoting signals that may encourage cancer cells. Carrying extra weight can also make treatment more difficult and increase side effects such as lymphedema and joint pain. Whether deliberately losing weight after diagnosis lowers recurrence risk is still being studied in large trials, and results are not yet conclusive. However, maintaining a healthy weight, being physically active and eating a balanced diet improve energy, reduce the risk of diabetes and heart disease, lower treatment side effects and support overall wellbeing, so they are recommended for breast cancer survivors. Gradual, sustainable weight loss through healthy eating and exercise is safest, ideally with help from a dietitian and after active treatment has finished.

Weight and outcomes are linked

Obesity is associated with higher recurrence risk in many studies.

Trials are ongoing

Large studies are testing whether weight loss after diagnosis improves outcomes.

Healthy habits help regardless

Activity and good nutrition improve many aspects of health.

South Asian women tend to carry more fat around the abdomen at lower body weights.

Lower healthy thresholds

Health risks rise at lower body mass index levels in Asian populations.

Waist matters

Measuring the waist can be more useful than weight alone.

Cultural food habits

Large portions of rice, sweets and fried snacks at festivals can add up. Planning helps.

Research on weight and breast cancer outcomes comes from several types of studies, each with strengths and limits.

Large observational studies

Studies following many thousands of women have found that those with obesity at diagnosis had a higher risk of recurrence and death from breast cancer. The link is generally stronger for hormone receptor positive cancer and postmenopausal women.

Weight gain after diagnosis

Some studies suggest that substantial weight gain after diagnosis is also linked with poorer outcomes, while modest changes may matter less.

Lifestyle intervention trials

Earlier trials of low-fat diets showed mixed results. One suggested fewer recurrences in some groups, particularly women with hormone receptor negative cancer who lost weight, but results were not consistent across studies.

Current large trials

Randomised trials are now testing structured weight loss programmes, combining diet, exercise and coaching, to see whether they directly reduce recurrence. Results will help guide future advice.

Other benefits already shown

Weight loss programmes have already been shown to improve fitness, reduce joint pain on hormone therapy, lower blood sugar and improve quality of life.

What this means now

While we wait for trial results, reaching and keeping a healthy weight is a sensible, low-risk goal for most survivors.